https://orcid.org/0000-0003-3174-8583
Abstract
Blood clots are complex structures composed of blood cells and proteins held together by a structural framework provided by an insoluble fibrin network. Factor (F)XIII is a protransglutaminase essential for stabilizing the fibrin network. Activated FXIII(a) introduces novel covalent cross-links within and between fibrin and other plasma and cellular proteins and thereby promotes fibrin biochemical and mechanical integrity. These irreversible modifications are also major determinants of clot composition and functional properties. As such, FXIII has central roles in hemostasis and wound healing, thrombosis, and many proinflammatory diseases associated with coagulation activation. The biochemical properties of FXIII are as interesting as its biology is unusual, giving rise to unique and still undefined mechanisms. Here, we review features underlying FXIII biology, biochemical function, biophysical impact, and (patho)physiologic implications in hemostasis, thrombosis, and disease.
References
1.
Weisel
JW
. Structure of fibrin: impact on clot stability
. J Thromb Haemost
. 2007
;5
(suppl 1
):116
-124
.2.
Lord
ST
. Fibrinogen and fibrin: scaffold proteins in hemostasis
. Curr Opin Hematol
. 2007
;14
(3
):236
-241
.3.
Lauer
P
, Metzner
HJ
, Zettlmeissl
G
, et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit
. Thromb Haemost
. 2002
;88
(6
):967
-974
.4.
Hsieh
L
, Nugent
D
. Factor XIII deficiency
. Haemophilia
. 2008
;14
(6
):1190
-1200
.5.
Tabibian
S
, Motlagh
H
, Naderi
M
, Dorgalaleh
A
. Intracranial hemorrhage in congenital bleeding disorders
. Blood Coagul Fibrinolysis
. 2018
;29
(1
):1
-11
.6.
Naderi
M
, Zarei
T
, Haghpanah
S
, Eshghi
P
, Miri-Moghaddam
E
, Karimi
M
. Intracranial hemorrhage pattern in the patients with factor XIII deficiency
. Ann Hematol
. 2014
;93
(4
):693
-697
.7.
Standeven
KF
, Carter
AM
, Grant
PJ
, et al. Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness
. Blood
. 2007
;110
(3
):902
-907
.8.
Helms
CC
, Ariëns
RA
, Uitte de Willige
S
, Standeven
KF
, Guthold
M
. α-α cross-links increase fibrin fiber elasticity and stiffness
. Biophys J
. 2012
;102
(1
):168
-175
.9.
Laki
K
, Lorand
L
. On the solubility of fibrin clots
. Science
. 1948
;108
(2802
):280
.10.
Kolotylo
V
, Piwowarek
K
, Kieliszek
M
. Microbiological transglutaminase: biotechnological application in the food industry
. Open Life Sci
. 2023
;18
(1
):20220737
.11.
Katona
E
, Penzes
K
, Csapo
A
, et al. Interaction of factor XIII subunits
. Blood
. 2014
;123
(11
):1757
-1763
.12.
Muszbek
L
, Yee
VC
, Hevessy
Z
. Blood coagulation factor XIII: structure and function
. Thromb Res
. 1999
;94
(5
):271
-305
.13.
Wölpl
A
, Lattke
H
, Board
PG
, et al. Coagulation factor XIII A and B subunits in bone marrow and liver transplantation
. Transplantation
. 1987
;43
(1
):151
-153
.14.
Beckers
CML
, Simpson
KR
, Griffin
KJ
, et al. Cre/lox studies identify resident macrophages as the major source of circulating coagulation factor XIII-A
. Arterioscler Thromb Vasc Biol
. 2017
;37
(8
):1494
-1502
.15.
Cordell
PA
, Kile
BT
, Standeven
KF
, Josefsson
EC
, Pease
RJ
, Grant
PJ
. Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion
. Blood
. 2010
;115
(13
):2674
-2681
.16.
Strilchuk
AW
, Meixner
SC
, Leung
J
, et al. Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency
. Blood
. 2020
;136
(25
):2946
-2954
.17.
Souri
M
, Koseki-Kuno
S
, Takeda
N
, Degen
JL
, Ichinose
A
. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice
. Int J Hematol
. 2008
;87
(1
):60
-68
.18.
Yorifuji
H
, Anderson
K
, Lynch
GW
, Van de Water
L
, McDonagh
J
. B protein of factor XIII: differentiation between free B and complexed B
. Blood
. 1988
;72
(5
):1645
-1650
.19.
Lovejoy
AE
, Reynolds
TC
, Visich
JE
, et al. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in subjects with factor XIII deficiency
. Blood
. 2006
;108
(1
):57
-62
.20.
Jamil
MA
, Singh
S
, El-Maarri
O
, Oldenburg
J
, Biswas
A
. Exploring diverse coagulation factor XIII subunit expression datasets: a bioinformatic analysis
. Int J Mol Sci
. 2022
;23
(9
):4725
.21.
Byrnes
JR
, Lee
T
, Sharaby
S
, et al. Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration
. Blood
. 2024
;143
(5
):444
-455
.22.
Singh
S
, Nazabal
A
, Kaniyappan
S
, et al. The plasma factor XIII heterotetrameric complex structure: unexpected unequal pairing within a symmetric complex
. Biomolecules
. 2019
;9
(12
):765
.23.
Protopopova
AD
, Ramirez
A
, Klinov
DV
, Litvinov
RI
, Weisel
JW
. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy
. J Thromb Haemost
. 2019
;17
(5
):737
-748
.24.
Greenberg
CS
, Shuman
MA
. The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen
. J Biol Chem
. 1982
;257
(11
):6096
-6101
.25.
Siebenlist
KR
, Meh
DA
, Mosesson
MW
. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains
. Biochemistry
. 1996
;35
(32
):10448
-10453
.26.
Smith
KA
, Adamson
PJ
, Pease
RJ
, et al. Interactions between factor XIII and the alphaC region of fibrinogen
. Blood
. 2011
;117
(12
):3460
-3468
.27.
Aleman
MM
, Byrnes
JR
, Wang
J-G
, et al. Factor XIII activity mediates red blood cell retention in venous thrombi
. J Clin Invest
. 2014
;124
(8
):3590
-3600
.28.
Byrnes
JR
, Wilson
C
, Boutelle
AM
, et al. The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues 390-396 and the FXIII-B subunits
. Blood
. 2016
;128
(15
):1969
-1978
.29.
Pénzes
K
, Bécsi
B
, Erdödi
F
, Muszbek
L
. Molecular interactions of coagulation factor XIII B subunit [abstract]
. Res Pract Thromb Haemost
. 2021
;5
(suppl 2
):LPB0111
.30.
Souri
M
, Osaki
T
, Ichinose
A
. The non-catalytic B subunit of coagulation factor XIII accelerates fibrin cross-linking
. J Biol Chem
. 2015
;290
(19
):12027
-12039
.31.
Souri
M
, Yokoyama
C
, Osaki
T
, Ichinose
A
. Antibodies against noncatalytic B subunit of factor XIII inhibit activation of factor XIII and fibrin crosslinking
. Thromb Haemost
. 2023
;123
(9
):841
-854
.32.
Singh
S
, Hagelueken
G
, Ugurlar
D
, et al. Cryo-EM structure of the human native plasma coagulation factor XIII complex
. Blood
. 2025
;145
(4
):438
-449
.33.
Bridey
F
, Negrier
C
, Duval
C
, Ariens
R
, de Moerloose
P
, Casini
A
. Impaired factor XIII activation in patients with congenital afibrinogenemia
. Haematologica
. 2019
;104
(3
):e111
-e113
.34.
Hurjak
B
, Kovacs
Z
, Donczo
B
, et al. N-glycosylation of blood coagulation factor XIII subunit B and its functional consequence
. J Thromb Haemost
. 2020
;18
(6
):1302
-1309
.35.
Anokhin
BA
, Stribinskis
V
, Dean
WL
, Maurer
MC
. Activation of factor XIII is accompanied by a change in oligomerization state
. FEBS J
. 2017
;284
(22
):3849
-3861
.36.
Hornyak
TJ
, Shafer
JA
. Role of calcium ion in the generation of factor XIII activity
. Biochemistry
. 1991
;30
(25
):6175
-6182
.37.
Bagoly
Z
, Haramura
G
, Muszbek
L
. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot
. Thromb Haemost
. 2007
;98
(2
):359
-367
.38.
Hur
WS
, Mazinani
N
, Lu
XJ
, et al. Coagulation factor XIIIa is inactivated by plasmin
. Blood
. 2015
;126
(20
):2329
-2337
.39.
Schmitt
LR
, Henderson
R
, Barrett
A
, et al. Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots
. J Biol Chem
. 2019
;294
(22
):8773
-8778
.40.
Keski-Oja
J
, Mosher
DF
, Vaheri
A
. Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII
. Cell
. 1976
;9
(1
):29
-35
.41.
Hada
M
, Kaminski
M
, Bockenstedt
P
, McDonagh
J
. Covalent crosslinking of von Willebrand factor to fibrin
. Blood
. 1986
;68
(1
):95
-101
.42.
Hethershaw
EL
, Cilia La Corte
AL
, Duval
C
, et al. The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis
. J Thromb Haemost
. 2014
;12
(2
):197
-205
.43.
Kurniawan
NA
, Grimbergen
J
, Koopman
J
, Koenderink
GH
. Factor XIII stiffens fibrin clots by causing fiber compaction
. J Thromb Haemost
. 2014
;12
(10
):1687
-1696
.44.
Piechocka
IK
, Kurniawan
NA
, Grimbergen
J
, Koopman
J
, Koenderink
GH
. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening
. J Thromb Haemost
. 2017
;15
(5
):938
-949
.45.
Feller
T
, Connell
SDA
, Ariёns
RAS
. Why fibrin biomechanical properties matter for hemostasis and thrombosis
. J Thromb Haemost
. 2022
;20
(1
):6
-16
.46.
Byrnes
JR
, Duval
C
, Wang
Y
, et al. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking
. Blood
. 2015
;126
(16
):1940
-1948
.47.
Duval
C
, Baranauskas
A
, Feller
T
, et al. Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi
. Proc Natl Acad Sci USA
. 2021
;118
(27
):e2103226118
.48.
Fraser
SR
, Booth
NA
, Mutch
NJ
. The antifibrinolytic function of factor XIII is exclusively expressed through α-antiplasmin cross-linking
. Blood
. 2011
;117
(23
):6371
-6374
.49.
Rijken
DC
, Abdul
S
, Malfliet
JJ
, Leebeek
FW
, Uitte de Willige
S
. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII
. J Thromb Haemost
. 2016
;14
(7
):1453
-1461
.50.
Karai
B
, Gyurina
K
, Ujfalusi
A
, et al. Expression patterns of coagulation factor XIII subunit A on leukemic lymphoblasts correlate with clinical outcome and genetic subtypes in childhood B-cell progenitor acute lymphoblastic leukemia
. Cancers
. 2020
;12
(8
):2264
.51.
Torocsik
D
, Bardos
H
, Nagy
L
, Adany
R
. Identification of factor XIII-A as a marker of alternative macrophage activation
. Cell Mol Life Sci
. 2005
;62
(18
):2132
-2139
.52.
Torocsik
D
, Szeles
L
, Paragh
G
, et al. Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages
. Thromb Haemost
. 2010
;104
(4
):709
-717
.53.
Kradin
RL
, Lynch
GW
, Kurnick
JT
, Erikson
M
, Colvin
RB
, McDonagh
J
. Factor XIII A is synthesized and expressed on the surface of U937 cells and alveolar macrophages
. Blood
. 1987
;69
(3
):778
-785
.54.
Alshehri
FSM
, Whyte
CS
, Tuncay
A
, Williams
ML
, Wilson
HM
, Mutch
NJ
. Monocytes expose factor XIII-A and stabilize thrombi against fibrinolytic degradation
. Int J Mol Sci
. 2021
;22
(12
):6591
.55.
Porrello
A
, Leslie
PL
, Harrison
EB
, et al. Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
. Nat Commun
. 2018
;9
(1
):1988
.56.
Shubin
NJ
, Glukhova
VA
, Clauson
M
, et al. Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation
. J Allergy Clin Immunol
. 2017
;139
(1
):323
-334
.57.
Piliponsky
AM
, Sharma
K
, Quach
P
, et al. Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections
. J Clin Invest
. 2022
;132
(20
):e157999
.58.
Muszbek
L
, Adany
R
, Kavai
M
, Boda
Z
, Lopaciuk
S
. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity
. Thromb Haemost
. 1988
;59
(2
):231
-235
.59.
Malara
A
, Gruppi
C
, Rebuzzini
P
, et al. Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A
. Blood
. 2011
;117
(8
):2476
-2483
.60.
Zeiler
M
, Moser
M
, Mann
M
. Copy number analysis of the murine platelet proteome spanning the complete abundance range
. Mol Cell Proteomics
. 2014
;13
(12
):3435
-3445
.61.
Kattula
S
, Byrnes
JR
, Martin
SM
, et al. Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice
. Blood Adv
. 2018
;2
(1
):25
-35
.62.
Burkhart
JM
, Vaudel
M
, Gambaryan
S
, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways
. Blood
. 2012
;120
(15
):e73
-e82
.63.
Katona E
E
, Ajzner
E
, Toth
K
, Karpati
L
, Muszbek
L
. Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates
. J Immunol Methods
. 2001
;258
(1-2
):127
-135
.64.
Kiesselbach
TH
, Wagner
RH
. Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique
. Ann N Y Acad Sci
. 1972
;202
:318
-328
.65.
Adany
R
, Kiss
A
, Muszbek
L
. Factor XIII: a marker of mono- and megakaryocytopoiesis
. Br J Haematol
. 1987
;67
(2
):167
-172
.66.
Mills
EW
, Green
R
, Ingolia
NT
. Slowed decay of mRNAs enhances platelet specific translation
. Blood
. 2017
;129
(17
):e38
-e48
.67.
Kristiansen
GK
, Andersen
MD
. Reversible activation of cellular factor XIII by calcium
. J Biol Chem
. 2011
;286
(11
):9833
-9839
.68.
Muszbek
L
, Haramura
G
, Polgar
J
. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets
. Thromb Haemost
. 1995
;73
(4
):702
-705
.69.
Anokhin
BA
, Dean
WL
, Smith
KA
, et al. Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A
. FEBS J
. 2020
;287
(3
):452
-464
.70.
Sixma
JJ
, van den Berg
A
, Schiphorst
M
, Geuze
HJ
, McDonagh
J
. Immunocytochemical localization of albumin and factor XIII in thin cryo sections of human blood platelets
. Thromb Haemost
. 1984
;51
(3
):388
-391
.71.
Mitchell
JL
, Lionikiene
AS
, Fraser
SR
, Whyte
CS
, Booth
NA
, Mutch
NJ
. Functional factor XIII-A is exposed on the stimulated platelet surface
. Blood
. 2014
;124
(26
):3982
-3990
.72.
Somodi
L
, Beke Debreceni
I
, Kis
G
, et al. Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles
. J Thromb Haemost
. 2022
;20
(5
):1223
-1235
.73.
Sang
Y
, Lee
RH
, Luong
A
, et al. Activated platelets retain and protect most of their factor XIII-A cargo from proteolytic activation and degradation
. Blood Adv
. 2024
;8
(19
):5072
-5085
.74.
Hevessy
Z
, Haramura
G
, Boda
Z
, Udvardy
M
, Muszbek
L
. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets
. Thromb Haemost
. 1996
;75
(1
):161
-167
.75.
Cohen
I
, Blankenberg
TA
, Borden
D
, Kahn
DR
, Veis
A
. Factor XIIIa-catalyzed cross-linking of platelet and muscle actin. Regulation by nucleotides
. Biochim Biophys Acta
. 1980
;628
(3
):365
-375
.76.
Cohen
I
, Young-Bandala
L
, Blankenberg
TA
, Siefring
GE
, Bruner-Lorand
J
. Fibrinoligase-catalyzed cross-linking of myosin from platelet and skeletal muscle
. Arch Biochem Biophys
. 1979
;192
(1
):100
-111
.77.
Serrano
K
, Devine
DV
. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation
. Thromb Haemost
. 2002
;88
(2
):315
-320
.78.
Zhu
Y
, Tassi
L
, Lane
W
, Mendelsohn
ME
. Specific binding of the transglutaminase, platelet factor XIII, to HSP27
. J Biol Chem
. 1994
;269
(35
):22379
-22384
.79.
Kasahara
K
, Souri
M
, Kaneda
M
, Miki
T
, Yamamoto
N
, Ichinose
A
. Impaired clot retraction in factor XIII A subunit-deficient mice
. Blood
. 2010
;115
(6
):1277
-1279
.80.
Mitchell
JL
, Little
G
, Bye
AP
, et al. Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability
. Res Pract Thromb Haemost
. 2023
;7
(5
):100200
.81.
Aleman
MM
, Holle
LA
, Stember
KG
, Devette
CI
, Monroe
DM
, Wolberg
AS
. Cystamine preparations exhibit anticoagulant activity
. PLoS One
. 2015
;10
(4
):e0124448
.82.
Buitrago
L
, Lefkowitz
S
, Bentur
O
, Padovan
J
, Coller
B
. Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking
. Blood Adv
. 2021
;5
(20
):3986
-4002
.83.
Jelenska
M
, Kopec
M
, Breddin
K
. On the retraction of collagen and fibrin induced by normal, defective and modified platelets
. Haemostasis
. 1985
;15
(3
):169
-175
.84.
Rao
KM
, Newcomb
TF
. Clot retraction in a factor XIII free system
. Scand J Haematol
. 1980
;24
(2
):142
-148
.85.
Dale
GL
, Friese
P
, Batar
P
, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface
. Nature
. 2002
;415
(6868
):175
-179
.86.
Jobe
SM
, Leo
L
, Eastvold
JS
, et al. Role of FcRgamma and factor XIIIA in coated platelet formation
. Blood
. 2005
;106
(13
):4146
-4151
.87.
Tacke
F
, Fiedler
K
, von Depka
M
, et al. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease
. Liver Int
. 2006
;26
(2
):173
-181
.88.
Lorenz
R
, Born
P
, Olbert
P
, Classen
M
. Factor XIII substitution in ulcerative colitis
. Lancet
. 1995
;345
(8947
):449
-450
.89.
Chamouard
P
, Grunebaum
L
, Wiesel
ML
, et al. Significance of diminished factor XIII in Crohn's disease
. Am J Gastroenterol
. 1998
;93
(4
):610
-614
.90.
Ogawa
T
, Morioka
Y
, Inoue
T
, Takano
M
, Tsuda
S
. Involvement of blood coagulation factor XIII in burn healing in the carbon tetrachloride-induced hepatic injury model in rats
. Inflamm Res
. 1995
;44
(6
):264
-268
.91.
Lawrie
AS
, Green
L
, Mackie
IJ
, Liesner
R
, Machin
SJ
, Peyvandi
F
. Factor XIII--an under diagnosed deficiency--are we using the right assays?
. J Thromb Haemost
. 2010
;8
(11
):2478
-2482
.92.
Javed
H
, Singh
S
, Ramaraje Urs
SU
, Oldenburg
J
, Biswas
A
. Genetic landscape in coagulation factor XIII associated defects - advances in coagulation and beyond
. Blood Rev
. 2023
;59
:101032
.93.
Menegatti
M
, Palla
R
, Boscarino
M
, et al; PRO-RBDD study group
. Minimal factor XIII activity level to prevent major spontaneous bleeds
. J Thromb Haemost
. 2017
;15
(9
):1728
-1736
.94.
Rea
CJ
, Foley
JH
, Sorensen
B
. Factor XIII in the treatment of hemophilia A
. N Engl J Med
. 2012
;366
(3
):281
-283
.95.
Rea
CJ
, Foley
JH
, Okaisabor
O
, Sorensen
B
. FXIII: mechanisms of action in the treatment of hemophilia A
. J Thromb Haemost
. 2014
;12
(2
):159
-168
.96.
Beckman
JD
, Holle
LA
, Wolberg
AS
. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking
. J Thromb Haemost
. 2018
;16
(1
):131
-141
.97.
Wolberg
AS
, Rosendaal
FR
, Weitz
JI
, et al. Venous thrombosis
. Nat Rev Dis Pri
. 2015
;1
(1
):15006
.98.
Byrnes
JR
, Wolberg
AS
. Newly-recognized roles of factor XIII in thrombosis
. Semin Thromb Hemost
. 2016
;42
(4
):445
-454
.99.
Catto
AJ
, Kohler
HP
, Coore
J
, Mansfield
MW
, Stickland
MH
, Grant
PJ
. Association of a common polymorphism in the factor XIII gene with venous thrombosis
. Blood
. 1999
;93
(3
):906
-908
.100.
Ariëns
RA
, Philippou
H
, Nagaswami
C
, Weisel
JW
, Lane
DA
, Grant
PJ
. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure
. Blood
. 2000
;96
(3
):988
-995
.101.
Lim
BC
, Ariëns
RA
, Carter
AM
, Weisel
JW
, Grant
PJ
. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk
. Lancet
. 2003
;361
(9367
):1424
-1431
.102.
Wolberg
AS
. Fibrinogen and fibrin: synthesis, structure, and function in health and disease
. J Thromb Haemost
. 2023
;21
(11
):3005
-3015
.103.
Kattula
S
, Bagoly
Z
, Toth
NK
, Muszbek
L
, Wolberg
AS
. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations
. J Thromb Haemost
. 2020
;18
(4
):885
-894
.104.
Kool
RO
, Kohler
HP
, Coutinho
JM
, et al. Coagulation factor XIII-A subunit and activation peptide levels in individuals with established symptomatic acute deep vein thrombosis
. Thromb Res
. 2017
;159
:96
-99
.105.
Kucher
N
, Schroeder
V
, Kohler
HP
. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness
. Thromb Haemost
. 2003
;90
(3
):434
-438
.106.
Shaya
SA
, Gani
DM
, Weitz
JI
, Kim
PY
, Gross
PL
. Factor XIII prevents pulmonary emboli in mice by stabilizing deep vein thrombi
. Thromb Haemost
. 2019
;119
(6
):992
-999
.107.
Kattula
S
, Sang
Y
, de Ridder
G
, et al. Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk
. J Thromb Haemost
. 2021
;19
(12
):2997
-3007
.108.
Girolami
A
, Cosi
E
, Tasinato
V
, Peroni
E
, Girolami
B
, Lombardi
AM
. Pulmonary embolism in congenital bleeding disorders: intriguing discrepancies among different clotting factors deficiencies
. Blood Coagul Fibrinolysis
. 2016
;27
(5
):517
-525
.109.
Tang
Z
, Kattula
S
, Holle
LA
, Cooley
BC
, Lin
FC
, Wolberg
AS
. Factor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in mice
. Res Pract Thromb Haemost
. 2020
;4
(1
):111
-116
.110.
Leidy
EM
, Stern
AM
, Friedman
PA
, Bush
LR
. Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis
. Thromb Res
. 1990
;59
(1
):15
-26
.111.
Shebuski
RJ
, Sitko
GR
, Claremon
DA
, Baldwin
JJ
, Remy
DC
, Stern
AM
. Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator
. Blood
. 1990
;75
(7
):1455
-1459
.112.
Schmitz
T
, Bauml
CA
, Imhof
D
. Inhibitors of blood coagulation factor XIII
. Anal Biochem
. 2020
;605
:113708
.113.
Myneni
VD
, Mousa
A
, Kaartinen
MT
. Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet
. Sci Rep
. 2016
;6
:35574
.114.
Hur
WS
, King
KC
, Patel
YN
, et al. Elimination of fibrin polymer formation or crosslinking, but not fibrinogen deficiency, is protective against diet-induced obesity and associated pathologies
. J Thromb Haemost
. 2022
;20
(12
):2873
-2886
.115.
Kopec
AK
, Abrahams
SR
, Thornton
S
, et al. Thrombin promotes diet-induced obesity through fibrin-driven inflammation
. J Clin Invest
. 2017
;127
(8
):3152
-3166
.116.
Flick
MJ
, Du
X
, Witte
DP
, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo
. J Clin Invest
. 2004
;113
(11
):1596
-1606
.117.
Joshi
N
, Kopec
AK
, Ray
JL
, et al. Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism
. Blood
. 2016
;127
(22
):2751
-2762
.118.
Wei
Z
, Groeneveld
DJ
, Adelmeijer
J
, et al. Coagulation factor XIII is a critical driver of liver regeneration after partial hepatectomy
. J Thromb Haemost
. 2024
;22
(3
):620
-632
.119.
Groeneveld
D
, Pereyra
D
, Veldhuis
Z
, et al. Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans
. Blood
. 2019
;133
(11
):1245
-1256
.120.
Andersson
C
, Kvist
PH
, McElhinney
K
, et al. Factor XIII transglutaminase supports the resolution of mucosal damage in experimental colitis
. PLoS One
. 2015
;10
(6
):e0128113
.121.
Steinbrecher
KA
, Horowitz
NA
, Blevins
EA
, et al. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen
. Cancer Res
. 2010
;70
(7
):2634
-2643
.122.
Neisser-Svae
A
, Hegener
O
, Gorlinger
K
. Differences in the biochemical composition of three plasma derived human fibrinogen concentrates
. Thromb Res
. 2021
;205
:44
-46
.123.
Baüml
CA
, Schmitz
T
, Paul George
AA
, et al. Coagulation factor XIIIa-inhibitor Tridegin: on the role of disulfide bonds for folding, stability, and function
. J Med Chem
. 2019
;62
(7
):3513
-3523
.© 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2025
You do not currently have access to this content.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal